Physician profile
Son T Le
NPI 1861441552
$2,584.40
in general payments reported to CMS, 2019-2025
18 companies · $93.99 in 2025
The $93.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,230 · 2020: $17.98 · 2021: $115 · 2022: $365 · 2023: $618 · 2024: $144 · 2025: $93.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $473.79 | 2019-2023 | Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.53 | 2019-2023 | Jardiance |
| Redhill Biopharma INC. | $237.97 | 2024-2025 | Talicia |
| Abbott Laboratories | $230.08 | 2019 | |
| Celgene Corporation | $133.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $128.57 | 2019 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Leo Pharma INC. | $125.00 | 2023 | Adbry |
| Amgen INC. | $124.55 | 2023 | Repatha |
| Abbvie INC. | $119.21 | 2019 | |
| Intercept Pharmaceuticals, INC. | $119.03 | 2023 | Ocaliva |
| Novo Nordisk INC | $115.36 | 2021 | |
| Nestle Healthcare Nutrition INC. | $115.01 | 2022 | |
| Amarin Pharma, INC. | $100.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.53 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $69.25 | 2019 | |
| Genentech USA, INC. | $17.98 | 2020 | |
| Nevro Corp. | $14.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.